Frontline Genomics talks to Ranga Sarangarajan about our AI guided GBM trials

BERG’s Chief Scientific Officer, Ranga Sarangarajan talks to Liz Harley at Frontline Genomics about our Phase I/II glioblastoma multiforme trials that are being guided by BERG’s AI platform. Learn more here.